ARTERIAL GIPERTONIYA DAVOSIDA VALODIP KOMBINATSIYASINING SAMARADORLIGI
##article.subject##:
valodip kombinatsiyasi, siydik albumini, antigipertenziv preparatlar kombinatsiyasi##article.abstract##
Gipertoniya kasalligi asosiy va to‘satdan paydo bo‘ladigan belgi sifatida qon bosimining ko‘tarilishi bilan tavsiflanadi. Arterial gipertoniya yurak-qon tomir tizimining eng keng tarqalgan kasalliklaridan biridir. Arterial gipertenziya dunyodagi katta yoshli aholining taxminan 20-30% ga ta’sir qiladi. Kasallikning tarqalishi 65 yoshdan oshgan odamlarda yoshga qarab 50-65% ga yetadi va yurak xuruji va insult rivojlanishiga olib kelishi mumkin. Hozirgi vaqtda arterial gipertenziyani o‘rganish katta ahamiyatga ega, chunki aholining 8-10 foizi ushbu kasallikdan aziyat chekadi va o‘limning asosiy sabablaridan biri hisoblanadi. Gipertoniya kasalligi tibbiyot amaliyotida keng tarqalgan. Ularni o‘z vaqtida aniqlash kasallikni davolash samaradorligini oshiradigan samarali va xavfsiz antigipertenziv dori vositalarining kombinatsiyasini o‘rganishni talab qiladi.
Библиографические ссылки
Efficacy of single-pill combination in uncontrolled essential hypertension: A systematic review and network meta-analysis. DOI: 10.1002/clc.24082
Efficacy and effectiveness of valsartan/amlodipine and valsartan/amlodipine/hydrochlorothiazide in hypertension: randomized controlled versus observational studies.doi: 10.3389/fphar.2023.1264321.
"Valsartan/Amlodipine Combination Therapy in Hypertension Management" – an article in Hypertension from the American Heart Association examines the efficacy and tolerability of this combination in patients with various forms of hypertension. More information can be found here: Hypertension Journal.
“Fixed-Dose Combination of Valsartan and Amlodipine for Hypertension Treatment” For more information: ScienceDirect.
Philipp T et al. Two multicenter, 8-week, randomized, double-blind,
placebo-controlled, parallel-group studies evaluating the efficacy and
tolerability of amlodipine and valsartan in combination and as
monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther 2007; 29 (4): 563–80
Smith TR et al. Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies. J Clin Hypertens
(Greenwich) 2007; 9: 355–64.
Poldermans D et al. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Clin Ther 2007; 29: 279–89
Allemann Y et al. A randomized, double-blind, multicenter study to
evaluate the efficacy of the combination of amlodipine and valsartan in
hypertensive patients uncontrolled on previous monotherapy: The EXFAST Study. J Clin Hypertens 2008; 10 (3): 185–94.
Braun N et al. Efficacy and safety of the single pill combination of
amlodipine 10mg plus valsartan 160 mg in hypertensive patients not
controlled by amlodipine 10mg plus olmesartan 20 mg in free combination. Current Medical Research and Opinion, 2009; 25 (2):
–30.
Arterial hypertension. diseases.medelement.com/disease/артериальная-гипертензия-2019/16296
